Rating History for BridgeBio Oncology Therapeutics, In (BBOT) by JPMorgan

More Stocks Rated by JPMorgan | Latest Ratings for BBOT
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/14/2026 Priyanka Grover Maintain Overweight
(Overweight)		 25.00
(27.00)		  
 		   Details